Preclinical Oncology Services Limited (PRECOS), a preclinical R&D service provider with a focus on oncology, has appointed Dr. Martin Page scientific consultant.

Page has more than 28 years of experience in oncology R&D leadership in the pharmaceutical and biotechnology sectors across the U.K., Europe and the U.S. He has led multiple teams discovering novel targeted small molecule and MAb anti-cancer agents that have entered clinical trials. Most recently, he was vice president, head of global oncology research, for Johnson & Johnson. Page has also held senior positions at Glaxo-Wellcome, Oxford GlycoSciences and Oncogene Sciences.